Combined Holdings of FATE in All ARK ETFs
Fate Therapeutics
FATE Therapeutics is a biopharmaceutical company that develops cellular immunotherapy treatments aimed at treating cancer and immune disorders. The company generates revenue through sales of its therapeutic products and by entering into collaborations and partnerships with other biotech firms and research institutions to advance its innovative treatments.
Trades of FATE in All Ark ETFs
The ten most recent trades of Fate Therapeutics in all the Ark ETFs ETF.View all trades
Date | Direction | Market Value | % of Position | % of ETF |
|---|---|---|---|---|
| Jan 23, 2023 | Sell | $286 | 100.00% | 0.00% |
| Jan 10, 2023 | Sell | $4,367 | 89.21% | 0.00% |
| Jan 10, 2023 | Sell | $5,940 | 100.00% | 0.00% |
| Jan 06, 2023 | Sell | $25,110 | 32.68% | 0.00% |
| Jan 06, 2023 | Sell | $81,826 | 34.48% | 0.00% |
| Jan 03, 2023 | Sell | $23,697,452 | 84.37% | 1.24% |
| Jan 03, 2023 | Sell | $11,888,082 | 81.44% | 0.20% |
| Dec 29, 2022 | Sell | $5,894,826 | 15.68% | 0.32% |
| Dec 29, 2022 | Sell | $28,155,265 | 45.46% | 0.49% |
| Dec 28, 2022 | Sell | $310,460 | 0.81% | 0.02% |